Sentinel lymph node biopsy for breast cancer

Richard J Bold, M. Schlieman, B. N. Fahy

Research output: Contribution to journalArticlepeer-review

6 Scopus citations


Sentinel lymph node biopsy (SLNB) is an emerging surgical technique to improve lymph node staging for breast cancer. Despite the rapid development of this technique, there remain aspects of SLNB that need to be further defined to provide a standardized approach. Variables, including patient selection, technical details for the performance of SLNB, extent of pathologic evaluation of the sentinel lymph node, and the impact of micrometastases, are areas of controversy. This paper reviews the controversies and discusses available data as well as personal experience and opinion.

Original languageEnglish (US)
Pages (from-to)347-357
Number of pages11
JournalCancer Biotherapy and Radiopharmaceuticals
Issue number5
StatePublished - 2001

ASJC Scopus subject areas

  • Cancer Research
  • Pharmacology
  • Oncology


Dive into the research topics of 'Sentinel lymph node biopsy for breast cancer'. Together they form a unique fingerprint.

Cite this